Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine
Part of paid clinical trials in Denver, Colorado.
- Sponsor
- University of Colorado, Denver
- Study ID
- NCT04611022
- Status
- Recruiting
Conditions
- Human Papilloma Virus
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- HPV Educational Intervention — BEHAVIORALThe videos are 8-minute narrative films created using an entertainment-education (E-E) approach that embeds an educational narrative message into an entertainment format such as media. E-E narratives have demonstrated a significant effect (r = .12, p \< .001) on health behavior change. Evidence-based small media interventions that Dr. Borrayo has produced include videos that are highly verbal, visual, and entertaining (e.g., acted fictional stories). The aims of the video will be to model uptake of the HPV vaccine, but also to reinforce self-efficacy, subjective norms, and behavioral intentions, all significant precursors to behavior change.
Study Details
The educational intervention to be delivered by the PN(Patient Navigator) consists of "toolkit education materials" developed by the National Cancer Institute (NCI) and a small media intervention (i.e., video) that our research team has developed. The NCI-produced toolkit education materials consist of Power Point presentations, flyers, and posters that contain information about HPV(Human Papilloma Virus), HPV-related cancers, and the importance of the HPV vaccine series for adolescents (9-17 years old) and young adults (18-26 year old) who are eligible for the vaccine.
Key Dates
- Start date
- Aug 28, 2020
- Status verified
- Nov 2025
- Primary completion
- Dec 31, 2027
- Completion
- Feb 1, 2028
Study Design
- Enrollment
- 1,000 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- PREVENTION
Arms
- Experimental: Patients Eligible for HPV Vaccine
Primary Outcome Measure
The change in parents & young adults' knowledge & intentions to obtain the HPV vaccine [ Time Frame: Day 0/Baseline ]
Central Contacts
- Sindy Gonzalez303-724-5445
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Colorado Hospital | Denver | Colorado | 80237 | Evelinn Borrayo (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Denver, CO
By research site
Related Studies
- Merck IIT: RRP Pembro and LenvatinibEARLY_PHASE1 · Recruiting · Yale University · New Haven, Connecticut
- A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat CancerPHASE2 · Recruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- Multidimensional and Multimodal Profiling of Oropharyngeal CarcinomaRecruiting · Stanford University · Palo Alto, California
- Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIVPHASE1 · Not Yet Recruiting · Emory University · Atlanta, Georgia